Cargando…

Prevalence of Frailty and Evaluation of Associated Variables Among COPD Patients

RATIONALE: Frailty in chronic obstructive pulmonary disease (COPD) patients has been associated with a higher rate of incidents, longer duration of hospitalization, poorer quality of life, and higher mortality. OBJECTIVE: To measure the prevalence of frailty among COPD patients and to evaluate assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Dias, Lara de Souza, Ferreira, Anna Carolina Galvão, da Silva Junior, José Laerte Rodrigues, Conte, Marcus Barreto, Rabahi, Marcelo Fouad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297564/
https://www.ncbi.nlm.nih.gov/pubmed/32606644
http://dx.doi.org/10.2147/COPD.S250299
_version_ 1783547032407900160
author Dias, Lara de Souza
Ferreira, Anna Carolina Galvão
da Silva Junior, José Laerte Rodrigues
Conte, Marcus Barreto
Rabahi, Marcelo Fouad
author_facet Dias, Lara de Souza
Ferreira, Anna Carolina Galvão
da Silva Junior, José Laerte Rodrigues
Conte, Marcus Barreto
Rabahi, Marcelo Fouad
author_sort Dias, Lara de Souza
collection PubMed
description RATIONALE: Frailty in chronic obstructive pulmonary disease (COPD) patients has been associated with a higher rate of incidents, longer duration of hospitalization, poorer quality of life, and higher mortality. OBJECTIVE: To measure the prevalence of frailty among COPD patients and to evaluate associated variables. METHODS: A cross-sectional study. Subjects who visited a State Center for High-Cost Medicines to obtain free monthly COPD medicines were considered eligible. Individuals ≥40 years old who had a FEV(1)/FVC ratio of <0.7 post-bronchodilation were enrolled. The Fatigue, Resistance, Ambulation, Illnesses, and Loss of weight (FRAIL) scale, Medical Research Council dyspnea scale (MRC), COPD Assessment Test (CAT), a combination of CAT/MRC [(CAT/8)+MRC], and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) severity scale were used to evaluate the enrolled subjects. Variables associated with frailty were analyzed using an ordered logistic regression and a multivariate logistic regression. RESULTS: The prevalence of frailty and pre-frailty among the 153 COPD subjects enrolled was 50.3% (77/153) and 35.3% (54/153), respectively. Frailty scores were correlated with CAT (correlation coefficient [cc]: 0.52, p <0.001) and MRC (cc: 0.48, p <0.001). Ordinal regression models showed that MRC and CAT were associated with fragility (p <0.0001 for both models). Higher odds of frailty were observed in GOLD groups B (p = 0.04) and D (p = 0.02). Multiple logistic regression revealed that the combination CAT/MRC≥5.5 was associated with frailty (OR 6.73; p <0.0001) and had a specificity of 80.3%, sensitivity of 62.3%, and positive and negative predictive values of 76.2% and67.8%, respectively. CONCLUSION: Frailty prevalence was high and was correlated with higher MRC and CAT scores. The CAT/MRC combination [(CAT/8)+MRC] ≥5.5 was highly associated with frailty, suggesting that an additional specific evaluation for the presence of frailty is indicated.
format Online
Article
Text
id pubmed-7297564
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-72975642020-06-29 Prevalence of Frailty and Evaluation of Associated Variables Among COPD Patients Dias, Lara de Souza Ferreira, Anna Carolina Galvão da Silva Junior, José Laerte Rodrigues Conte, Marcus Barreto Rabahi, Marcelo Fouad Int J Chron Obstruct Pulmon Dis Original Research RATIONALE: Frailty in chronic obstructive pulmonary disease (COPD) patients has been associated with a higher rate of incidents, longer duration of hospitalization, poorer quality of life, and higher mortality. OBJECTIVE: To measure the prevalence of frailty among COPD patients and to evaluate associated variables. METHODS: A cross-sectional study. Subjects who visited a State Center for High-Cost Medicines to obtain free monthly COPD medicines were considered eligible. Individuals ≥40 years old who had a FEV(1)/FVC ratio of <0.7 post-bronchodilation were enrolled. The Fatigue, Resistance, Ambulation, Illnesses, and Loss of weight (FRAIL) scale, Medical Research Council dyspnea scale (MRC), COPD Assessment Test (CAT), a combination of CAT/MRC [(CAT/8)+MRC], and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) severity scale were used to evaluate the enrolled subjects. Variables associated with frailty were analyzed using an ordered logistic regression and a multivariate logistic regression. RESULTS: The prevalence of frailty and pre-frailty among the 153 COPD subjects enrolled was 50.3% (77/153) and 35.3% (54/153), respectively. Frailty scores were correlated with CAT (correlation coefficient [cc]: 0.52, p <0.001) and MRC (cc: 0.48, p <0.001). Ordinal regression models showed that MRC and CAT were associated with fragility (p <0.0001 for both models). Higher odds of frailty were observed in GOLD groups B (p = 0.04) and D (p = 0.02). Multiple logistic regression revealed that the combination CAT/MRC≥5.5 was associated with frailty (OR 6.73; p <0.0001) and had a specificity of 80.3%, sensitivity of 62.3%, and positive and negative predictive values of 76.2% and67.8%, respectively. CONCLUSION: Frailty prevalence was high and was correlated with higher MRC and CAT scores. The CAT/MRC combination [(CAT/8)+MRC] ≥5.5 was highly associated with frailty, suggesting that an additional specific evaluation for the presence of frailty is indicated. Dove 2020-06-12 /pmc/articles/PMC7297564/ /pubmed/32606644 http://dx.doi.org/10.2147/COPD.S250299 Text en © 2020 Dias et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Dias, Lara de Souza
Ferreira, Anna Carolina Galvão
da Silva Junior, José Laerte Rodrigues
Conte, Marcus Barreto
Rabahi, Marcelo Fouad
Prevalence of Frailty and Evaluation of Associated Variables Among COPD Patients
title Prevalence of Frailty and Evaluation of Associated Variables Among COPD Patients
title_full Prevalence of Frailty and Evaluation of Associated Variables Among COPD Patients
title_fullStr Prevalence of Frailty and Evaluation of Associated Variables Among COPD Patients
title_full_unstemmed Prevalence of Frailty and Evaluation of Associated Variables Among COPD Patients
title_short Prevalence of Frailty and Evaluation of Associated Variables Among COPD Patients
title_sort prevalence of frailty and evaluation of associated variables among copd patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297564/
https://www.ncbi.nlm.nih.gov/pubmed/32606644
http://dx.doi.org/10.2147/COPD.S250299
work_keys_str_mv AT diaslaradesouza prevalenceoffrailtyandevaluationofassociatedvariablesamongcopdpatients
AT ferreiraannacarolinagalvao prevalenceoffrailtyandevaluationofassociatedvariablesamongcopdpatients
AT dasilvajuniorjoselaerterodrigues prevalenceoffrailtyandevaluationofassociatedvariablesamongcopdpatients
AT contemarcusbarreto prevalenceoffrailtyandevaluationofassociatedvariablesamongcopdpatients
AT rabahimarcelofouad prevalenceoffrailtyandevaluationofassociatedvariablesamongcopdpatients